LCM

Lynx1 Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 143.06%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+143.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$2.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
27
New
Increased
Reduced
Closed

Top Buys

1
+$28.8M
2
+$24.9M
3
+$24.6M
4
KRRO icon
Korro Bio
KRRO
+$15.8M
5
XNCR icon
Xencor
XNCR
+$10.5M

Top Sells

1
+$144M
2
+$46.5M
3
+$5.3M
4
IBIO icon
iBio
IBIO
+$874K
5
ALLO icon
Allogene Therapeutics
ALLO
+$677K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STOK icon
1
Stoke Therapeutics
STOK
$1.77B
$172M 34.73%
5,404,674
GHRS icon
2
GH Research
GHRS
$932M
$132M 26.75%
10,406,575
+1,805,386
CGEM icon
3
Cullinan Oncology
CGEM
$776M
$92.8M 18.78%
8,963,500
+3,197,410
DNLI icon
4
Denali Therapeutics
DNLI
$3.18B
$28.7M 5.81%
1,738,750
+1,477,063
CCCC icon
5
C4 Therapeutics
CCCC
$262M
$13.6M 2.74%
7,098,133
XNCR icon
6
Xencor
XNCR
$850M
$10.8M 2.19%
+705,558
IMTX icon
7
Immatics
IMTX
$1.3B
$9.68M 1.96%
+921,950
TCRX icon
8
TScan Therapeutics
TCRX
$60.9M
$8.02M 1.62%
8,019,148
+161,801
PASG icon
9
Passage Bio
PASG
$22.6M
$7.36M 1.49%
623,704
KRRO icon
10
Korro Bio
KRRO
$113M
$5.43M 1.1%
+677,915
DTIL icon
11
Precision BioSciences
DTIL
$174M
$4.13M 0.84%
993,913
-48,683
NEUP
12
Neuphoria Therapeutics
NEUP
$24.6M
$3.4M 0.69%
+875,228
AGIO icon
13
Agios Pharmaceuticals
AGIO
$1.65B
$2.17M 0.44%
+79,624
CGON icon
14
CG Oncology
CGON
$5.44B
$1.31M 0.27%
+31,591
ARWR icon
15
Arrowhead Research
ARWR
$7.94B
$800K 0.16%
+12,043
DSGN icon
16
Design Therapeutics
DSGN
$587M
$652K 0.13%
69,516
+3,562
TRDA icon
17
Entrada Therapeutics
TRDA
$455M
$531K 0.11%
+51,689
HOWL icon
18
Werewolf Therapeutics
HOWL
$40.9M
$416K 0.08%
+655,926
MPLT
19
MapLight Therapeutics
MPLT
$772M
$237K 0.05%
+13,477
GBIO
20
DELISTED
Generation Bio
GBIO
$142K 0.03%
+25,000
PRQR icon
21
ProQR Therapeutics
PRQR
$181M
$138K 0.03%
+68,486
APLT
22
DELISTED
Applied Therapeutics
APLT
$41K 0.01%
+410,500
ADCT icon
23
ADC Therapeutics
ADCT
$497M
– –
-1,325,848
ALLO icon
24
Allogene Therapeutics
ALLO
$483M
– –
-546,119
IBIO icon
25
iBio
IBIO
$75.7M
– –
-1,055,897
1
2